Navigation Links
Raviv Method to Offer First U.S. Practitioner Training Course
Date:3/18/2009

Novel approach improves reading and attention deficits in children and adults.

IRVINE, Calif., March 18 /PRNewswire/ -- The Raviv Method, an innovative neuro-cognitive approach to correcting learning and attention deficits associated with dyslexia, AD(H)D and related neurological disorders, will launch its first U.S. practitioner training course in Los Angeles on April 25. The course is open to special needs professionals and educators, parents of children with attention or learning difficulties, or those interested in therapeutic treatment for cognitive deficiencies.

Developed by Nili Raviv nearly 14 years ago, the Raviv Method is effective for individuals with dyslexia, dyspraxia, dysgraphia, dyscalculia, as well as neurological problems like AD(H)D and conditions resulting from brain damage. The Method is based on permanently improving the coordination and synchronization of the brain's neural systems and changing the way the brain functions, contravening traditional methods which teach people to cope with their disabilities rather than dealing with the problem at its core. The training corrects any gaps in the development stages of learning and enables the formation of new neural circuits where vital connections must be created between different parts of the brain.

"Our program has helped thousands of children in Israel and Europe achieve a breakthrough in learning where conventional therapies were ineffective," said Nili Raviv from the Raviv Method Learning Center in Haifa, Israel. "I'm pleased to bring this ground-breaking approach and our successful track record to the special needs community in the U.S."

With centers in Israel, London and Ireland, the program has trained more than 500 practitioners to work with children and adults in private, school and group settings. The practitioner training course comprises three core modules that provide a basic understanding of the brain's functions, an in-depth understanding of the theory and principles behind the Raviv Method and the ability to treat clients hands-on. Licensed practitioner status is granted upon completion of the training program.

Besides enhancing learning skills, the method has been found to improve behavior and organizational skills and self esteem and to lower anxiety.

The Practitioner Training Course begins Saturday, April 25 and runs for three weekends through May 17. For more information or to register for the course, contact Dvora Shpun, Certified Raviv Method Practitioner at 949-679-2430; Shpun_d@yahoo.com. Media inquiries contact Lisa Armony at 949-279-2011 or lisaarmony@cox.net. See also www.ravivmethod.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Nili Raviv

http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87022


'/>"/>
SOURCE The Raviv Method
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Air Methods Announces Year 2008 Financial Results and Provides First Quarter 2009 Update
2. Clinical trial finds microbicide promising as HIV prevention method for women
3. Air Methods to Report Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, March 10, 2009
4. Water method for unsedated colonoscopy; interval between prep and colonoscopy predicts prep quality
5. Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method
6. Scripps research scientists develop general-purpose method for detecting trace chemicals
7. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
8. A useful method to diagnose chest pain with foregut symptoms
9. Innovative method to starve tumors
10. Early Detection Methods for Pancreatic Cancer Urgently Needed: A Statement From the Pancreatic Cancer Action Network
11. UC San Diego engineers develop novel method for accelerated bone growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: